AnalystsMatt PhippsMatt Phipps's Stock Forecasts
AnalystsMatt Phipps
Sectors:
Industries:
Analyst Ranking
Bottom 8%
#4235 out of 4554 analysts
Average Return
-57.43%
Win Rate
11%1 out of 9
Risk vs Reward
Poor
Good
Matt Phipps's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Merus NvMRUS | +24.52% | $23.29 | $29.00 | 2021-04-07 - 2022-04-07 | Buy |
Matt Phipps Analyst Color
Get additional color on Matt Phipps's coverage of popular stocks
Matt Phipps's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Janux Therapeutics IncJANX | 1 | Buy | N/A | N/A | Initiates Coverage On | a year ago |
Genmab AGMAB | 1 | Hold | N/A | N/A | Initiates Coverage On | a year ago |
Phasebio Pharmaceuticals IncPHASQ | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Aileron Therapeutics IncALRN | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Mink Therapeutics IncINKT | 1 | Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Jasper Therapeutics IncJSPR | 1 | Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Biogen IncBIIB | 1 | Buy | N/A | N/A | Upgrades | 3 years ago |
Ikena Oncology IncIKNA | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Merus NvMRUS | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
F Star Therapeutics IncFSTX | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Kezar Life Sciences IncKZR | 1 | Buy | N/A | N/A | Initiates Coverage On | 6 years ago |
Pieris Pharmaceuticals IncPIRS | 1 | Buy | N/A | N/A | Initiates Coverage On | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.